Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) Stock Overview
Explore Vera Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.9B
P/E Ratio
-10.59
EPS (TTM)
$-3.99
ROE
-0.51%
VERA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vera Therapeutics, Inc. (VERA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $44.41.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.59 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.